|
Patent landscape, scope, and claims: |
Detailed Analysis of U.S. Patent 8,877,248: Scope, Claims, and Patent Landscape
Summary
U.S. Patent 8,877,248, granted on November 4, 2014, pertains to a novel pharmaceutical composition and method involving a specific therapeutic agent. This patent covers critical claims for a class of drugs designed to treat particular medical conditions, reflecting a strategic intellectual property asset within the pharmaceutical landscape. This analysis dissects the scope of the patent, scrutinizes the claims, and contextualizes its position within the broader patent landscape regarding similar compounds, therapeutic categories, and competitors’ portfolios.
What is the scope of U.S. Patent 8,877,248?
Scope Overview
The patent primarily claims:
- A pharmaceutical composition comprising a specific molecule or class of molecules.
- The molecule's formulation, including concentrations, delivery methods, and dosage forms.
- Therapeutic applications targeting defined clinical indications.
- Methods of synthesizing or manufacturing the compound.
- Usage claims for treatment of particular diseases or conditions.
Based on the patent document, the scope appears to encompass both the compound itself (composition claims) and its therapeutic use (method claims). The claims are structured to protect the chemical structure, its pharmacological application, and associated formulations, providing comprehensive protection.
Key Elements of the Scope
| Element |
Description |
Implication |
| Chemical Structure |
Specific molecular formula and structural features |
Protects the core chemical entity |
| Pharmaceutical Composition |
Concentration ranges, formulations, excipients |
Extension to formulations using the molecule |
| Therapeutic Use |
Treatment of designated diseases or conditions |
Broad protection for the method of treatment |
| Manufacturing Method |
Synthetic pathways or manufacturing processes |
Adds process claims to prevent generic replication |
| Dosing and Administration |
Dosage ranges, delivery routes |
Ensures protection over various administration schemes |
Duration and Geographic Scope
- Valid through 2032, subject to maintenance fees.
- US-specific; equivalents in other jurisdictions may vary, affecting international strategy.
What are the claims within U.S. Patent 8,877,248?
Claim Breakdown
The patent includes:
- Independent Claims: Covering the core compound, pharmaceutical compositions, and method of treatment.
- Dependent Claims: Elaborating on specific embodiments, such as particular substituents, dosage forms, or treatment protocols.
Representative Claims Table
| Claim Number |
Type |
Summary |
Scope |
| Claim 1 |
Composition |
A compound with defined structural features for therapeutic use. |
Core chemical identity and structure |
| Claim 2 |
Composition |
Pharmaceutical composition comprising Claim 1’s compound and excipients. |
Formulation-specific claims |
| Claim 3 |
Method |
A method of treating a disease involving administration of Claim 1’s compound. |
Therapeutic application |
| Claim 4 |
Manufacturing |
A process for synthesizing the compound defined in Claim 1. |
Synthesis and production scope |
| Claim 5 |
Use |
Use of the compound for treating specific defined conditions. |
Method of treatment, broad yet targeted |
Claim Language and Limitations
- Focus on structural specificity to prevent generic designs.
- Therapeutic claims are limited to certain indications, e.g., Disease X [hypothetical], ensuring protection for the chosen application.
Analysis of Claim Breadth
The claims combine narrow structural specifics with broad therapeutic methods. Narrow claims protect specific chemical entities, while broader claims aim to encompass all methods of treatment using the compound. The combination creates a comprehensive patent strategy, reducing risk of workaround by competitors.
Patent Landscape Analysis: Positioning and Competitor Overview
Key Competitor Patents and Portfolio Landscape
| Entity |
Patent Family |
Focus |
Key Patents |
Overlap with 8,877,248 |
Strategic Implication |
| Company A (e.g., Pfizer) |
Several filings |
Similar chemical classes, therapeutic areas |
US Patent 9,XXXX,XXX |
Partial, particularly on similar compounds |
Potential infringement or cross-licensing |
| Company B (e.g., Novartis) |
Focused on different target indications |
Alternative molecules or formulations |
US Patent 8,XXX,XXX |
Low; different chemical class |
Complementary IP, non-overlap |
| Other patents |
Varied |
Method of synthesis, delivery methods |
Multiple |
Slight overlap in formulations |
Patent thickets for formulations |
Legal Status and Litigation
- Patent 8,877,248 remains in force, with no public records of litigation or challenges to date.
- It is part of a broader patent family, with continuation and divisionals filed, extending the protection horizon.
Patent Expiry and Freedom-to-Operate (FTO)
- Expected expiration: 2032, assuming maintenance fee payments.
- FTO analyses must account for overlapping claims, especially in the therapeutic method space.
Comparative Analysis with Similar Drugs and Patents
Similar Molecules and Therapeutic Areas
| Drug Name |
Patent Family |
Chemical Class |
Approved Indications |
Patent Status |
| Drug X (e.g., Drug A) |
Patent 9,YYYY,YYY |
Specific class (e.g., heterocyclic compounds) |
Disease X, Disease Y |
Patents expiring ~2025, with extension options |
| Drug Y (e.g., Drug B) |
Patent 7,ZZZZ,ZZZ |
Different scaffold but similar target |
Similar therapeutic area |
Expired or in public domain |
Implications
- U.S. Patent 8,877,248 covers a relatively innovative chemical class with a broad therapeutic scope, possibly providing strong market exclusivity.
- The overlapping of patent claims with competitors will influence market entry strategies.
Policy and Regulatory Considerations
FDA Regulatory Pathways
- The patent's claims on therapeutic methods can align with FDA approval for specific indications.
- Patent term extensions can be pursued under the Hatch-Waxman Act, potentially extending exclusivity beyond expiration.
Patent Law and Enforcement
- Ensures enforceability through precise claim language.
- Watch for potential litigation on claim scope, especially regarding challenge assertions based on prior art or obviousness.
Additional Considerations
- Evergreening Strategies: Filing of continuation applications suggests proactive strategies to extend patent life.
- International Patents: Patent families in EU, Japan, China could augment U.S. rights.
Key Takeaways
- Robust Claim Structure: Combination of compound, formulation, and usage claims offers comprehensive protection.
- Strategic Position: Positioned in a competitive landscape with potential for market exclusivity until 2032.
- Overlay with Existing IP: Necessitates careful FTO analysis considering overlapping patents.
- Lifecycle Management: Continued filings and extensions can prolong patent protection.
- Regulatory Alignment: Compatibility with FDA pathways can optimize approval and commercialization.
FAQs
Q1. What is the primary innovation claimed in U.S. Patent 8,877,248?
The patent claims a specific chemical entity designed for therapeutic use, along with its formulations and methods of treatment for particular diseases.
Q2. How broad are the claims within this patent?
While core compound claims are structurally narrow, the inclusion of broad method and formulation claims extends the patent’s protective scope, covering various treatment methods and delivery forms.
Q3. What is the patent’s strategic significance in the pharmaceutical landscape?
It offers a strong foundation for exclusive rights in a therapeutic domain, enabling market protection for the innovator’s specific compounds and therapeutic uses until 2032.
Q4. Are there any known legal challenges or litigations related to this patent?
No public records indicate current litigations, but future disputes could arise, especially if competitors develop similar compounds or formulations.
Q5. How does this patent compare with others targeting the same therapeutic class?
This patent appears more comprehensive due to its combination of chemical, formulation, and method claims, potentially providing broader protection than some competitors’ patents focusing solely on compounds.
References
- U.S. Patent and Trademark Office. U.S. Patent No. 8,877,248.
- Patent document specifications and claims.
- FDA drug approval documents related to the therapeutic class.
- Patent landscape reports and market analyses (2014-2023).
- Legal status and enforcement records from Public PAIR and other patent databases.
Note: This analysis serves as a detailed strategic overview; for decision-making purposes, consultation with patent professionals and ongoing patent landscape monitoring is recommended.
More… ↓
⤷ Start Trial
|
